AHRMM is offering a repository for leading and proven supply chain practices, case studies, and toolkits that are developed from a Cost, Quality, and Outcomes (CQO) perspective. The following Catheter Acquired Urinary Tract Infection (CAUTI) leading practice was submitted by:
Blue.Point Supply Chain Solutions, Andover, MA
Knowledge Center
682 Results Found
AHRMM is offering a repository for leading and proven supply chain practices, case studies, and toolkits that are developed from a Cost, Quality, and Outcomes (CQO) perspective. The following Catheter Acquired Urinary Tract Infections (CAUTI) leading practice was submitted by:
Nexera, Inc., New York, NY
AHRMM is offering a repository for leading and proven supply chain practices, case studies, and toolkits that are developed from a Cost, Quality, and Outcomes (CQO) perspective. The following Catheter Acquired Urinary Tract Infection (CAUTI) leading practice was submitted by:
AHRMM is offering a repository for leading and proven supply chain practices, case studies, and toolkits that are developed from a Cost, Quality, and Outcomes (CQO) perspective. The following Catheter Acquired Urinary Tract Infections (CAUTI) leading practice was submitted by:
AHRMM is developing a repository for leading and proven supply chain practices, case studies, and toolkits that are developed from a Cost, Quality, and Outcomes (CQO) perspective. The following CAUTI leading practice was submitted by:
University of Virginia Health System, Charlottesville, VA
Problem Statement: CAUTI rates exceeding national benchmark (NHSN).
Method:
The Patient Protection and Affordable Care Act of 2010 (ACA) requires the Secretary of Health and Human Services to establish a VBP program to pay hospitals for their actual performance on quality measures, rather than just the reporting of those measures, beginning in fiscal year (FY) 2013. The VBP program will apply to all acute-care prospective payment system (PPS) hospitals. Read a summary of key provisions of the proposed rule.
A sample of a general contractor RFP.
Read how UPMC Health System is improving lives through redefined models of health care delivery, technological innovation and cutting-edge medical research.
In this page, AHRMM recommends these 3 proactive activities in the event of economic downturn.
A sample of wholesale pharmacy distributor request for proposal.
Sample RFP for Wholesale Pharmacy Distributor
A sample of generic reference lab request for proposal.
In 2001 the Institute of Medicine (IOM) published
The Food and Drug Administration (FDA) UDI system is being phased in over several years. The first sunrise date (certain Class III devices) occurred 09/24/14. Recognizing UDI implementation will take time, healthcare supply chain and risk management professionals should be aware of already-implemented changes in the FDA’s adverse event reporting methodology. One of the changes required immediately is the use of the UDI in adverse event reporting.
This learning lab covers alarm safety management in the health care supply chain field.
This page provides information about submitting data to the database for device Labelers, entities responsible for providing the data to the GUDID.
This document provides interim guidance for infection control for healthcare facilities (e.g., hospitals, long-term care and outpatient facilities, and other settings where healthcare is provided).
New Guidance on Humidity Levels in the Operating Room
AHRMM’s Issues & Legislative Committee issued the following Statement on Pricing Transparency approved by AHRMM Board of Directors:
Sample landscaping services request for proposal (RFP).
Supply chain must play an integral role in the care delivery process through cross-departmental partnerships that support evidence-based value analysis. Michael Louviere, System VP of Supply Chain at OHS shares his insights on what he calls a 'new adventureattempting to support best practices by collecting clinical evidence and synthesizing it to ensure that clinical practice is based on integrating individual clinical expertise with the best available relevant external clinical evidence from systematic research.